Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors.

Saved in:
Bibliographic Details
Title: Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors.
Authors: Goebel L; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Kirschner T; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Koska S; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Rai A; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Janning P; Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Maffini S; Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Vatheuer H; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Czodrowski P; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Goody RS; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Müller MP; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Rauh D; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Source: ELife [Elife] 2023 Mar 27; Vol. 12. Date of Electronic Publication: 2023 Mar 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-084X
DOI:10.7554/eLife.82184